SkyePharma's asthma drug gets European marketing nod
Reuters Company sees launching drug across Europe in H2* Stock up 28 pct, top percentage gainer on LSEJuly 3 (Reuters) – Britain's SkyePharma Plc said itsasthma therapy Flutiform got marketing approval from. |
View full post on asthma – Google News